Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Corvus Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −4 vs. Q4 2022
- Shares held
- 20.8M
- −184.6K (−0.9%) vs. Q4 2022
- Total value
- $18.9M
- +$1.09M (+6.1%) vs. Q4 2022
- New holders
- 2
- 7 more added
- Sold out
- 6
- 5 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,943,654 | $6.32M | 0.13% | 00.0% | Unchanged |
| Adams Street Partners LLC | 3,275,616 | $2.98M | 0.93% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,339,402 | $2.13M | 0.57% | −45,000−1.9% | Reduced |
| Millennium Management LLC | 2,029,423 | $1.85M | 0.00% | +129,907+6.8% | Added |
| BVF Inc | 1,370,947 | $1.25M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,260,566 | $1.15M | 0.00% | 00.0% | Unchanged |
| Discovery Capital Management, LLC | 548,727 | $499.3K | 0.07% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 506,032 | $460.0K | 0.00% | −142,600−22.0% | Reduced |
| Artal Group S.A. | 500,000 | $455.0K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 493,222 | $448.8K | 0.00% | +2,441+0.5% | Added |
| Geode Capital Management, LLC | 297,800 | $271.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 204,047 | $185.7K | 0.00% | −77,140−27.4% | Reduced |
| Two Sigma Advisers, LP | 187,300 | $170.4K | 0.00% | −73,000−28.0% | Reduced |
| Bridgeway Capital Management, LLC | 159,300 | $145.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 131,771 | $119.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 112,603 | $102.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 100,159 | $91.1K | 0.00% | +27,554+38.0% | Added |
| Jackson Square Capital, LLC | 63,773 | $58.0K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 61,668 | $56.1K | 0.00% | 00.0% | Unchanged |
| Hikari Power Ltd | 49,959 | $45.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 30,000 | $27.3K | 0.00% | 00.0% | Unchanged |
| Commerce Bank | 20,000 | $18.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,354 | $18.0K | 0.00% | +596+3.2% | Added |
| Baader Bank INC | 24,911 | $17.7K | 0.00% | +24,911 | New |
| Tower Research Capital LLC (TRC) | 12,597 | $11.0K | 0.00% | −121−1.0% | Reduced |
| UBS Group AG | 11,014 | $10.0K | 0.00% | +6,314+134.3% | Added |
| Mercer Global Advisors Inc | 10,550 | $10.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 10,500 | $9.55K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,443 | $9.50K | 0.00% | +10,443 | New |
| Whittier Trust Co of Nevada Inc | 4,200 | $3.82K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,100 | $1.00K | 0.00% | +1,000+1,000.0% | Added |
| JPMorgan Chase & Co | 1,201 | $1.00K | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 500 | $455 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 238 | $217 | 0.00% | +3+1.3% | Added |
| IFP Advisors, Inc | 24 | $19 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $18 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −25,459−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −21,419−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,750−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,015−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −232−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Telemetry Investments, L.L.C. | – | – | – | – | Not filed |